
Alzheimer’s drug from Eisai and Biogen slows cognitive decline, side-effects in focus
By Deena Beasley SAN FRANCISCO (Reuters) -An experimental Alzheimer’s drug from Eisai and Biogen slo...
30th November, 2022

By Deena Beasley SAN FRANCISCO (Reuters) -An experimental Alzheimer’s drug from Eisai and Biogen slo...
30th November, 2022

By Catharina Eklof, CCO, IDEX Biometrics We are moving closer to a cashless society: 89% of payments...
29th November, 2022

By Ove Kreison, CTO at Estonian core banking provider Tuum. Digital transformation has dominated ind...
29th November, 2022

By Huw Jones, Iain Withers and Lawrence White LONDON (Reuters) -Britain will change its rulebook to...
29th November, 2022

By David Shepardson (Reuters) -Ford Motor Co is recalling 634,000 sport utility vehicles (SUVs) worl...
29th November, 2022

By Vignesh Ramesh, Head of Consumer Duty Solutions at Medallia The new Consumer Duty rules from the...
29th November, 2022

By Sune Engsig, vice president of product development, Leapwork Software plays a vital role in almos...
29th November, 2022

By Maeson Maherry, COO at Ascertia Companies consider digital transformation for many reasons. Some...
28th November, 2022

FRANKFURT (Reuters) – French bank Credit Agricole is weighing plans to offer car-sharing financial s...
28th November, 2022

By Libero Marconi, Director with Alvarez & Marsal and Vishal Pandey, Senior Director with Alvarez &...
25th November, 2022

By Nigel Verdon, CEO and co-founder of Railsr Embedded finance emerges The pandemic has accelerated...
25th November, 2022

By Erika founder of Beyond Governance Fintechs are innovative by nature, often growing quickly and r...
25th November, 2022